SDHB immunonegativity has been reported in pheochromocytoma/paraganglioma, GISTs, RCCs, PAs, pancreatic NETs, prostate cancer, stomach cancer, and testicular seminoma15,20,22–24,27,31. Here, SDHB is linked to prostate carcinoma.